Hemostatic factors according to menopausal status and use of hormone replacement therapy
- 31 July 1992
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 2 (4), 445-455
- https://doi.org/10.1016/1047-2797(92)90094-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Plasma Factor VII, Triglyceride Concentration and Fibrin Degradation Products in Primary Hyperlipidemia: A Clinical and Laboratory StudyPathophysiology of Haemostasis and Thrombosis, 1989
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- A novel form of factor VII in plasma from men at risk for cardiovascular diseaseBritish Journal of Haematology, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting.BMJ, 1975